Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
5.9K
Cancer02:18

Cancer

55.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.0K
3.0K
Cancer Prevention02:59

Cancer Prevention

8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.

Radiology·2026
Same author

Microwave Ablation for Colorectal Liver Metastases: If Your Margin Is Less than 10 mm, Your Intention Is Not Curative.

Radiology·2026
Same author

Combination Systemic Chemotherapy and Ablation Treatment for Potentially Curable Patients with Colorectal Liver Metastases: Ablate Completely and Ablate Early.

Radiology·2023
Same author

CT-Guided Celiac Ganglion Block for Neurogenic Gastrointestinal Dysmotility.

Journal of vascular and interventional radiology : JVIR·2022
Same author

Spontaneous breast hematoma as a complication of anticoagulation therapy requiring angiography and embolization.

Clinical imaging·2020
Same author

Another Milestone for Cryoablation on Its Way to Becoming the Standard of Care for Stage T1A Renal Cell Carcinoma.

Radiology·2020
Same journal

Present and Emerging Strategies for Disease Assessment in Hodgkin Lymphoma.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Management of Classic Hodgkin Lymphoma in Special Clinical Situations.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Older Patients With Hodgkin Lymphoma: A Contemporary Review.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Adolescent and Young Adult Patients With Classical Hodgkin Lymphoma: A Review as a Case Study in AYA Cancer Care.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Hodgkin Lymphoma: Management of Patients Who Fail Primary Therapy.

Cancer journal (Sudbury, Mass.)·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

753

Kidney Cancer.

S Brandon Hancock1, Christos S Georgiades

  • 1From the *Vascular & Interventional Radiology and †Department of Radiology & Radiological Sciences, Johns Hopkins University, Baltimore, MD.

Cancer Journal (Sudbury, Mass.)
|November 22, 2016
PubMed
Summary
This summary is machine-generated.

Image-guided percutaneous ablation, including cryoablation, is a viable and safe curative option for early-stage renal cell carcinoma. Emerging oncologic data suggests its efficacy rivals traditional nephron-sparing surgery.

More Related Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.3K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Related Experiment Videos

Last Updated: Mar 11, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

753
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.3K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Area of Science:

  • Oncology
  • Urology
  • Minimally Invasive Surgery

Background:

  • Renal cell carcinoma (RCC) incidence has risen, with most tumors detected incidentally at early stages.
  • Nephron-sparing surgery is the standard of care for early-stage RCC, offering good survival and safety.
  • Image-guided percutaneous ablation has emerged as a potential alternative due to technological advancements.

Purpose of the Study:

  • To evaluate the efficacy and safety of image-guided percutaneous ablation for stage I renal cell carcinoma.
  • To compare ablation outcomes with the current standard of care, nephron-sparing surgery.
  • To assess the role of ablation in managing early-stage renal tumors.

Main Methods:

  • Review of recent studies providing prospective, long-term oncologic data on percutaneous ablation modalities (radiofrequency, microwave, cryoablation).
  • Analysis of ablation's application in early-stage renal cancer, including specific patient subgroups.
  • Comparison of oncologic outcomes and safety profiles between ablation and nephron-sparing surgery.

Main Results:

  • Percutaneous ablation, particularly cryoablation, demonstrates efficacy rivaling nephron-sparing surgery for stage IA RCC.
  • Ablation offers a favorable safety profile, potentially mitigating surgical risks.
  • Long-term oncologic data now supports the use of ablation, moving beyond its initial reservation for specific patient groups.

Conclusions:

  • Image-guided percutaneous ablation is a viable, curative treatment option for stage IA renal cell carcinoma.
  • Ablation presents a compelling alternative to surgery, especially considering its safety advantages.
  • Continued research and data collection affirm ablation's role in modern RCC management.